Although galectin-3's relationship with cardiovascular events in CKD is less consistent, increased levels correlate with endothelial dysfunction and inflammation, suggesting its involvement in vascular pathology within CKD populations (138). Here, LGALS3 is linked to endothelial dysfunction.